Who owns Portela?
Portela is owned by Zoetis (the United States, NYSE: ZTS).[1]
Evidence: Zoetis Inc. Annual Report on Form 10-K filed 2026-02-12, SEC EDGAR, 12 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Zoetis Inc. verified
- Owner HQ
- 🇺🇸 United States, Parsippany, New Jersey
- Origin
- 🇺🇸 United States
- Founded
- 2025
- Category
- Pet & animal care › Pet supplies & services › Veterinary services
- Parent ticker
- NYSE: ZTS
- Trademark registrant
- Zoetis Services LLC (USPTO)
- Last verified
- · 2 sources
About Portela
Portela is the newest of Zoetis's osteoarthritis antibodies, approved in the European Union and Canada in 2025. Its active ingredient is relfovetmab and it is dosed once every three months rather than monthly, which Zoetis describes as the first long-acting injectable antibody therapy for the relief of osteoarthritis pain in cats. It extends the franchise that Solensia opened for feline chronic pain.
How often Zoetis names Portela in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central. The brand is named more often than it was three years earlier.
Trademark record for Portela
The USPTO record for the Portela mark lists Zoetis Services LLC as the owner of record (serial number 98421073). That name matches the owner named above.[2]
Ownership timeline of Portela
Where Portela sits in Zoetis
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Zoetis ownership tree →
See the full Zoetis brand portfolio (17) →
Other brands owned by Zoetis
Zoetis controls 17 brands on Brandtree, 17 of them in pet & animal care.
Also in pet & animal care
Other brands in veterinary services, and who owns them
Zoetis has more brands in veterinary services on Brandtree than any other owner: 17 of 45.
About the owner: Zoetis
Zoetis is a publicly listed company headquartered in Parsippany, New Jersey, United States, founded in 2012. Brandtree records 17 brands under its control, and it is listed as NYSE: ZTS.
Zoetis is the largest animal health company in the world by revenue, selling medicines, vaccines and diagnostics for pets and livestock. It was incorporated in Delaware in July 2012 out of what had been a business unit of Pfizer, and it markets directly in about 45 countries while selling in more than 100. Companion animals now dominate: its two biggest lines, the Simparica parasiticides and the Apoquel dermatology range, were 16 and 12 per cent of 2025 revenue, and it left the medicated feed additive business entirely in 2024.
🇺🇸 Portela and other American brands
Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Portela is not one of them.
- 4health — Tractor Supply 🇺🇸
- Advantage — Elanco 🇺🇸
- American Journey — Chewy 🇺🇸
- Aqueon — Central Garden & Pet 🇺🇸
- Aureomycin — Phibro 🇺🇸
- BARK — BARK 🇺🇸
Frequently asked questions
Who is the parent company of Portela?
The parent company of Portela is Zoetis, a publicly listed company headquartered in the United States.
Is Portela American?
Yes. Portela originated in the United States in 2025 and its owner, Zoetis, is also headquartered in the United States.
Is Portela still owned by Zoetis?
Yes. As of 27 September 2026, Portela is still owned by Zoetis. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Zoetis Inc. Annual Report on Form 10-K filed 2026-02-12 — SEC EDGAR, SEC Form 10-K, published 12 February 2026; retrieved 25 September 2026.
- [2] USPTO: PORTELA, serial 98421073 — United States Patent and Trademark Office, Trademark registry; retrieved 27 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.